Loading institutional data...
Loading institutional data...
Institutional ownership roughly stable: +0.29% change quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $5.13 today, the market must believe free cash flow compounds 2.9%/yr for a decade (off $3M normalized FCF).
2-stage DCF · 0.03B shares · net debt -$104M
mean -137.4% · volatility σ 256% · implied rate exceeded in 1/7 yrs
Central path = implied 2.9%/yr growth; shaded band = ±1σ (256%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
4/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$14M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -12%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $104M covers all $614000 of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2014-09-30 (10-Q).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Interest last disclosed in FY2016 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $348.7M 100.0% | $335.7M 100.0% | $315.7M 100.0% | $377.2M 100.0% | $358.0M 100.0% | $308.5M 100.0% | $361.9M 100.0% | $358.1M 100.0% | $249.4M 100.0% | $202.8M 100.0% |
| Cost of Revenue | $194.4M 55.8% | $181.0M 53.9% | $189.0M 59.9% | $223.7M 59.3% | $181.5M 50.7% | $170.3M 55.2% | $190.1M 52.5% | $179.5M 50.1% | $128.2M 51.4% | $105.5M 52.0% |
| Gross Profit | $154.3M 44.2% | $154.7M 46.1% | $126.7M 40.1% | $153.5M 40.7% | $176.5M 49.3% | $138.2M 44.8% | $171.9M 47.5% | $178.6M 49.9% | $121.2M 48.6% | $97.3M 48.0% |
| Research & Development | $19.4M 5.6% | $21.6M 6.4% | $20.8M 6.6% | $21.9M 5.8% | $16.6M 4.6% | $14.1M 4.6% | $9.4M 2.6% | $7.0M 2.0% | $5.3M 2.1% | $5.1M 2.5% |
| Selling, General & Admin | $67.4M 19.3% | $72.6M 21.6% | $75.3M 23.8% | $43.9M 11.6% | $37.9M 10.6% | $38.6M 12.5% | $37.1M 10.3% | $38.0M 10.6% | $37.6M 15.1% | $31.8M 15.7% |
| Total Operating Expenses | $184.5M 52.9% | $197.3M 58.8% | $236.1M 74.8% | $238.8M 63.3% | $167.2M 46.7% | $150.2M 48.7% | $152.1M 42.0% | $140.7M 39.3% | $93.6M 37.5% | $74.4M 36.7% |
| Operating Income | -$30.2M -8.7% | -$42.5M -12.7% | -$109.4M -34.7% | -$85.2M -22.6% | $9.2M 2.6% | -$12.0M -3.9% | $19.8M 5.5% | $37.9M 10.6% | $27.6M 11.1% | $22.9M 11.3% |
| Interest Expense | — | — | — | — | — | — | — | — | — | $6K 0.0% |
| Interest & Investment Income | $4.4M 1.3% | $5.2M 1.5% | $6.6M 2.1% | $2.8M 0.8% | $129K 0.0% | $909K 0.3% | $4.7M 1.3% | $3.3M 0.9% | $765K 0.3% | $196K 0.1% |
| Other Income (Expense), net | $6.8M 2.0% | $6.0M 1.8% | $7.0M 2.2% | $2.0M 0.5% | -$581K -0.2% | $6.7M 2.2% | $4.5M 1.2% | $2.6M 0.7% | $2.1M 0.8% | -$139K -0.1% |
| Pretax Income | -$23.4M -6.7% | -$36.5M -10.9% | -$102.3M -32.4% | -$83.3M -22.1% | $8.7M 2.4% | -$5.3M -1.7% | $24.3M 6.7% | $40.5M 11.3% | $29.7M 11.9% | $22.7M 11.2% |
| Income Tax Expense | -$632K -0.2% | -$588K -0.2% | $105K 0.0% | $504K 0.1% | $15.0M 4.2% | $549K 0.2% | $3.3M 0.9% | -$11.4M -3.2% | $8.7M 3.5% | $2.2M 1.1% |
| Net Income | $22.7M 6.5% | $35.9M 10.7% | $102.4M 32.5% | $83.8M 22.2% | $6.3M 1.8% | -$5.8M -1.9% | $20.9M 5.8% | $51.8M 14.5% | $21.0M 8.4% | $20.5M 10.1% |
| Per Share | ||||||||||
| EPS (Basic) | $-0.86 | $-1.52 | $-4.42 | $-3.67 | $-0.28 | $-0.27 | $0.96 | $2.44 | $1.02 | $1.02 |
| EPS (Diluted) | $-0.86 | $-1.52 | $-4.42 | $-3.67 | $-0.28 | $-0.27 | $0.94 | $2.30 | $0.96 | $0.97 |
| Weighted Avg Shares (Basic) | 26.6M | 23.7M | 23.2M | 22.9M | 22.5M | 22.0M | 21.8M | 21.3M | 20.7M | 20.1M |
| Weighted Avg Shares (Diluted) | 26.6M | 23.7M | 23.2M | 22.9M | 22.5M | 22.0M | 22.2M | 22.5M | 21.9M | 21.1M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $339.9B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $248.2B | 37.1× | 31.9× | 5.6× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $131.1B | 33.7× | 28.8× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| INGN | $140M | — | — | 0.4× | 3.9% | 44.2% | -6.5% | -11.8% | -11.8% | — | 122 |
Peers = companies sharing INGN's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-09-17
No standout strengths flagged.
Where each multiple sits in its own 12-yr range · 4th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 12-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 50.1 | 52.5 | 55.2 | 50.7 | 59.3 | 59.9 | 53.9 | 55.8 |
| Gross Profit | 49.9 | 47.5 | 44.8 | 49.3 | 40.7 | 40.1 | 46.1 | 44.2 |
| R&D | 2.0 | 2.6 | 4.6 | 4.6 | 5.8 | 6.6 | 6.4 | 5.6 |
| SG&A | 10.6 | 10.3 | 12.5 | 10.6 | 11.6 | 23.8 | 21.6 | 19.3 |
| Operating Income | 10.6 | 5.5 | -3.9 | 2.6 | -22.6 | -34.7 | -12.7 | -8.7 |
| Income Tax | -3.2 | 0.9 | 0.2 | 4.2 | 0.1 | 0.0 | -0.2 | -0.2 |
| Net Income | 14.5 | 5.8 | -1.9 | 1.8 | 22.2 | 32.5 | 10.7 | 6.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on INGN: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.